3 months | 6 months | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Intervention n = 152–155 | Control n = 157–159 | Intervention n = 124–127 | Control n = 133–141 | ||||||||
Median | IQR | Median | IQR | p-value* | Median | IQR | Median | IQR | p-value* | ||
Psychological symptoms | Somatisation | 0.7 | 0.3–1.1 | 0.8 | 0.3–1.3 | 0.09 | 0.6 | 0.3–1.0 | 0.7 | 0.3–1.3 | 0.20 |
Anxiety | 0.6 | 0.2–1.1 | 0.8 | 0.3–1.3 | 0.04 | 0.4 | 0.2–0.9 | 0.6 | 0.2–1.2 | 0.09 | |
Interpersonal sensitivity | 0.7 | 0.4–1.2 | 0.9 | 0.4–1.6 | 0.08 | 0.7 | 0.2–1.2 | 1.0 | 0.3–1.4 | 0.10 | |
Depression | 1.0 | 0.5–1.7 | 1.3 | 0.7–2.3 | 0.02 | 0.8 | 0.5–1.5 | 1.1 | 0.5–1.9 | 0.19 | |
Phobic anxiety | 0.1 | 0.0–0.6 | 0.1 | 0.0–0.6 | 0.29 | 0.1 | 0.0–0.4 | 0.1 | 0.0–0.4 | 0.27 | |
Obsessive-compulsive | 1.0 | 0.5–1.8 | 1.2 | 0.7–2.0 | 0.12 | 0.8 | 0.4–1.5 | 1.0 | 0.6–1.7 | 0.05 | |
Locus of control | Internal LOC | 23.0 | 19.0–28.0 | 20.0 | 16.0–25.0 | <0.001 | 24.0 | 19.5–28.0 | 21.0 | 16.0–25.0 | <0.001 |
Chance | 14.0 | 11.0–18.0 | 14.5 | 11.0–18.0 | 0.23 | 14.0 | 9.0–18.0 | 14.0 | 10.0–18.0 | 0.43 | |
Doctors | 12.0 | 10.0–14.0 | 12.0 | 10.0–14.0 | 0.50 | 12.0 | 9.0–13.0 | 12.0 | 10.0–13.0 | 0.76 | |
Other people | 11.0 | 9.0–13.0 | 11.0 | 8.0–13.0 | 0.39 | 10.0 | 8.0–12.0 | 10.0 | 8.0–12.0 | 0.88 | |
Mental health related QoL | Vitality | 45.0 | 30.0–60.0 | 45.0 | 25.0–60.0 | 0.32 | 50.0 | 30.0–65.0 | 50.0 | 25.0–65.0 | 0.54 |
Social functioning | 75.0 | 62.5–100.0 | 87.5 | 62.5–100.0 | 0.98 | 87.5 | 75.0–100.0 | 87.5 | 62.5–100.0 | 0.58 | |
Role limitations due to emotional problems | 66.7 | 33.3–100.0 | 66.7 | 0.0–100.0 | 0.33 | 66.7 | 33.3–100.0 | 66.7 | 33.3–100.0 | 0.71 | |
Mental health | 64.0 | 52.0–76.0 | 60.0 | 44.0–76.0 | 0.04 | 68.0 | 56.0–80.0 | 68.0 | 52.0–78.0 | 0.41 |